Current Affairs
Israeli AI Cancer Startup Lands $5 Million
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- File format
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Science
- Vendor products
In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...
A pair of recently developed AI systems can diagnose lung cancer and heart disease more accurately than human doctors. These AIs have the potential to save billions of dollars and countless lives if widely adopted. Improved...
Irène Villa PhD, Marie-Christine Mathieu MD, Jacques Bosq MD, Anne Auperin PhD, Jean-François Pomerol PhD, Magali Lacroix-Triki MD PhD, Jean-Yves Scoazec MD PhD, Peggy Dartigues MD American Journal of Clinical Pathology,...
25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers. Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial...
As reported by GenomeWeb among many media outlets, in an anticipated move, the American Clinical Laboratory Association filed a lawsuit last Monday against Acting Secretary of the US Department of Health and Human Services Eric Hargan,...
SPOT CytoXpress™ Makes ROSE Consults Cost Effective
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- File format
- General Healthcare News
- Image Analysis
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
The CAP Cytopathology Committee found telepathology was the only cost effective method for ROSE (Rapid On-Site Evaluation) support of FNA/EBUS...































